[Progress in diagnostics and therapy of type 1 and type 2 diabetes--part 2].
The report is the second part of a former publication. The authors presented a series of reports, especially from the last year, concerned with diagnostics and therapy of type 1 and type 2 diabetes. The progress of the diagnostics included especially new, more perfect glycaemic monitoring systems. The progress and future of the therapy with personal insulin pumps and different international recommendations for the therapy of type 1 diabetes with short-acting insulin analogues were presented. Also, the problem of the reports about the increased risk of cancer after the treatment with a long-acting insulin analogue glargine was discussed (Lantus). Further investigations of the effect of the therapy with a biphasic insulin and new possibilities of oral therapy in type 2 diabetes were mentioned. It was stressed that actually, a lot of proposals of new drugs and new reports are observed. These reports are, however, frequently conference news and not complete reports and the proposals require further examinations and observations for a confirmed appreciation of their efficacy and safety.